We hope you'll be inspired by the dedication of our fundraisers and the expertise of our researchers who are all working together to tackle pancreatic cancer. This section covers news about PCRF-funded research as well as research into pancreatic cancer being carried out all over the world.
A team of researchers from Queen Mary University of London and Zhengzhou University in China have taken the first steps towards the development of a vaccine for pancreatic cancer.
Some 150 people attended the 2019 PCRF Supporters Conference at the Cavendish Conference Centre in London on 29 November.
A urine test that can detect early stage pancreatic cancer has reached the final stage of validation before being developed for use with patients.
Treatment of pancreatic cancer might be enhanced by zapping tumours with electricity alongside drug treatments, according to a PCRF-funded project at University College Cork.
PCRF-funded scientists have found a way to target and knock out a single protein that they have discovered is widely involved in pancreatic cancer cell growth, survival and invasion.
The recent news that the drug olaparib delayed the progress of advanced pancreatic cancer in patients who have faults in the BRCA1 and 2 genes underlines the relevance and importance of a PCRF-funded research project being carried out by Dr Mairéad McNamara from the University of Manchester and The Christie NHS Foundation Trust.
A ‘precision drug’ designed to target specific genetic faults within cancer cells has caused cautious excitement, by delaying the progression of some advanced pancreatic cancers after chemotherapy treatment.
Seven innovative research projects tackling pancreatic cancer have been awarded grants by the national charity Pancreatic Cancer Research Fund (PCRF) totalling £1.2M.
The first study in the world to take a detailed look at scar tissue that surrounds pancreatic cancer tumours – also known as the stroma - has revealed a range of different scar tissue types that could help clinicians predict which patients will respond best to particular treatments.
A new technique to study tissue samples in 3D has revealed that pancreatic cancers can start and grow in two distinct ways, solving a decades-old mystery of how tumours form.